NCT01685359View on ClinicalTrials.gov

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy
Interventions
DRUG

Epoetin Alfa

Intravenous administration for 4 weeks, three times a week (monday, wednesday, friday)

Trial Locations (1)

13276-245

LAL Clinica, Valinhos

All Listed Sponsors
lead

Azidus Brasil

INDUSTRY

NCT01685359 - PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant | Biotech Hunter | Biotech Hunter